首页 | 本学科首页   官方微博 | 高级检索  
检索        

甲状腺癌分子标志物的研究现状
引用本文:贾倩玉,张英霞.甲状腺癌分子标志物的研究现状[J].现代肿瘤医学,2019,0(5):902-905.
作者姓名:贾倩玉  张英霞
作者单位:内蒙古医科大学附属医院超声科,内蒙古 呼和浩特 010059
基金项目:内蒙古自治区自然科学基金(编号:2016MS0841)
摘    要:甲状腺癌是内分泌系统常见的恶性肿瘤,占所有恶性肿瘤的1%,通常分为乳头状癌、滤泡癌、髓样癌和未分化癌四种,对于甲状腺癌的临床诊断是现阶段临床工作关注的热点问题。临床上将触诊、超声检查及细针细胞学检查作为诊断的主要手段。近年来,对甲状腺癌分子标志物的研究越来越多,已将其应用于联合诊断甲状腺癌,协助甲状腺癌术前、术后的评估以及疾病监控等方面。

关 键 词:甲状腺癌  分子标志物  基因联合诊断

Thyroid cancer molecular markers research status
Jia Qianyu,Zhang Yingxia.Thyroid cancer molecular markers research status[J].Journal of Modern Oncology,2019,0(5):902-905.
Authors:Jia Qianyu  Zhang Yingxia
Institution:Department of Ultrasound,the Affiliated Hospital of Inner Mongolia Medical University,Inner Mongolia Hohhot 010059,China.
Abstract:Thyroid cancer is a common malignancy of the endocrine system and accounts for 1% of all malignant tumors.It is usually divided into papillary,follicular,medullary,and undifferentiated cancers.Clinical diagnosis of thyroid cancer is clinical work at this stage.Concerned hot issues.Palpation,ultrasonography and fine needle cytology are the main methods of diagnosis in clinical practice.In recent years,more and more studies have been done on molecular markers of thyroid cancer,and they are used in the combined diagnosis of thyroid cancer,and assist thyroid cancer preoperatively,postoperative assessment and disease surveillance.
Keywords:thyroid cancer  molecular markers  gene joint diagnosis
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号